StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies total assets

Total assets on the balance sheet at the end of each period.

Neuroone Medical Technologies's total assets was $6.19M at Jun 30, 2026. For fiscal 2025 it was $10.79M, up 100.9% from the year before. Over ten years it grew 169.9% a year on average. The highest annual figure on record is $12.82M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025$10.79M+100.9%
FY2024Sep 30, 2024$5.37M-33.7%
FY2023Sep 30, 2023$8.10M-36.9%
FY2022Sep 30, 2022$12.82M+61.5%
FY2021Sep 30, 2021$7.94M+66.8%
FY2020Sep 30, 2020$4.76M+1804.0%
FY2017Dec 31, 2017$249.99K-67.0%
FY2016Dec 31, 2016$756.93K+41082.3%
FY2015Dec 31, 2015$1.84K+796.6%
FY2014Dec 31, 2014$205-61.0%
FY2013Dec 31, 2013$525-53.0%
FY2012Dec 31, 2012$1.12K-91.9%
FY2011Dec 31, 2011$13.85K+51.7%
FY2010Dec 31, 2010$9.13K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$6.19M-42.8%
Q2 FY2026CQ1 2026Mar 31, 2026$7.57M+69.8%
Q1 FY2026CQ4 2025Dec 31, 2025$8.58M+32.1%
Q4 FY2025CQ3 2025Sep 30, 2025$10.79M+100.9%
Q3 FY2025CQ2 2025Jun 30, 2025$10.82M+120.2%
Q2 FY2025CQ1 2025Mar 31, 2025$4.46M-17.4%
Q1 FY2025CQ4 2024Dec 31, 2024$6.49M+11.5%
Q4 FY2024CQ3 2024Sep 30, 2024$5.37M-33.7%
Q3 FY2024CQ2 2024Jun 30, 2024$4.91M-14.7%
Q2 FY2024CQ1 2024Mar 31, 2024$5.39M-25.1%
Q1 FY2024CQ4 2023Dec 31, 2023$5.82M-39.7%
Q4 FY2023CQ3 2023Sep 30, 2023$8.10M-36.9%
Q3 FY2023CQ2 2023Jun 30, 2023$5.76M-50.2%
Q2 FY2023CQ1 2023Mar 31, 2023$7.21M-48.9%
Q1 FY2023CQ4 2022Dec 31, 2022$9.66M-43.8%
Q4 FY2022CQ3 2022Sep 30, 2022$12.82M+61.5%
Q3 FY2022CQ2 2022Jun 30, 2022$11.57M+18.0%
Q2 FY2022CQ1 2022Mar 31, 2022$14.09M+18.2%
Q1 FY2022CQ4 2021Dec 31, 2021$17.18M+117.2%
Q4 FY2021CQ3 2021Sep 30, 2021$7.94M+66.8%
Q3 FY2021CQ2 2021Jun 30, 2021$9.81M+119.8%
Q2 FY2021CQ1 2021Mar 31, 2021$11.92M+757.8%
Q1 FY2021CQ4 2020Dec 31, 2020$7.91M+197.6%
Q4 FY2020CQ3 2020Sep 30, 2020$4.76M+1804.0%
Q3 FY2020CQ2 2020Jun 30, 2020$4.46M+1566.3%
Q2 FY2020CQ1 2020Mar 31, 2020$1.39M–
Q1 FY2020CQ4 2019Dec 31, 2019$2.66M–
Q4 FY2017CQ4 2017Dec 31, 2017$249.99K-67.0%
Q3 FY2017CQ3 2017Sep 30, 2017$267.81K+6161.7%
Q2 FY2017CQ2 2017Jun 30, 2017$0-100.0%
Q1 FY2017CQ1 2017Mar 31, 2017$0-100.0%
Q4 FY2016CQ4 2016Dec 31, 2016$756.93K+41082.3%
Q3 FY2016CQ3 2016Sep 30, 2016$4.28K+2027.9%
Q2 FY2016CQ2 2016Jun 30, 2016$4.28K+1052.8%
Q1 FY2016CQ1 2016Mar 31, 2016$1.82K+831.3%
Q4 FY2015CQ4 2015Dec 31, 2015$1.84K+796.6%
Q3 FY2015CQ3 2015Sep 30, 2015$201–
Q2 FY2015CQ2 2015Jun 30, 2015$371–
Q1 FY2015CQ1 2015Mar 31, 2015$195–
Q4 FY2014CQ4 2014Dec 31, 2014$205–

More Neuroone Medical Technologies figures

See a number that looks wrong?